Xiangsheng Zuo Selected Research

Xiangsheng Zuo Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 03/2007
13	Carcinogenesis 01/2022 - 08/2003
11	Colonic Neoplasms (Colon Cancer) 06/2015 - 08/2003
6	Inflammation (Inflammations) 01/2022 - 03/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2003
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
2	Polyps 01/2022 - 07/2010
2	Obesity 10/2018 - 03/2013
1	Colonic Polyps 01/2022
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Dyslipidemias (Dyslipidemia) 10/2018
1	Atherosclerosis 10/2018
1	Insulin Resistance 10/2018
1	Colitis 01/2017
1	Adenocarcinoma 03/2016
1	Colitis-Associated Neoplasms 06/2015
1	Hypoxia (Hypoxemia) 06/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2007
5	PPAR deltaIBA 01/2022 - 08/2003
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 03/2013
4	AcidsIBA 01/2022 - 08/2003
4	AzoxymethaneIBA 01/2017 - 05/2009
3	villinIBA 01/2022 - 04/2014
3	Messenger RNA (mRNA)IBA 06/2015 - 03/2007
2	Linoleic Acid (Linoleate)IBA 01/2022 - 01/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 04/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2013
2	Leukotriene B4IBA 01/2022 - 07/2010
2	Lipoxygenase (Lipoxygenase-1)IBA 01/2022 - 07/2010
2	13-hydroxy-9,11-octadecadienoic acidIBA 01/2022 - 07/2010
2	CateninsIBA 01/2020 - 01/2019
2	CytokinesIBA 01/2019 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2018 - 09/2015
2	MethyltransferasesIBA 09/2017 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 06/2008
2	LipidsIBA 01/2017 - 06/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014 - 05/2009
2	Histones (Histone)IBA 12/2011 - 11/2008
2	Histone Deacetylase InhibitorsIBA 11/2008 - 03/2007
2	Small Interfering RNA (siRNA)IBA 06/2008 - 03/2007
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Oleic Acid (Oleate)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2022
1	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 01/2022
1	Vitamin D FDA LinkGeneric 05/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2021
1	GW 501516IBA 01/2019
1	4- chloro- N- (2- ((5- trifluoromethyl- 2- pyridyl)sulfonyl)ethyl)benzamideIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	3,3'-diindolylmethane (diindolylmethane)IBA 09/2017
1	Differentiation AntigensIBA 09/2017
1	LipoxinsIBA 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	CarcinogensIBA 01/2017
1	Biological ProductsIBA 03/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2013
1	EicosanoidsIBA 07/2013
1	LigandsIBA 03/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2011
1	ChromatinIBA 11/2008
1	GATA6 Transcription FactorIBA 03/2007
1	RNA (Ribonucleic Acid)IBA 03/2007
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 03/2007
1	Butyric Acid (Butanoic Acid)IBA 03/2007
1	Pharmaceutical PreparationsIBA 03/2007
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 03/2007
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2003

Therapy/Procedure

2	Therapeutics 05/2021 - 09/2015
1	Immunotherapy 05/2021